Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review

ConclusionsAlthough inclusion of productivity losses/gains was shown to have a favorable impact on evaluations for many studies, their impact and method of calculation was often not reported or was unclear. Further examination and discussion is needed to consider the optimal framework for considering productivity losses/gains in cost-effectiveness analyses, including the appropriate cost elements to include (e.g., patient absenteeism, caregiver absenteeism, presenteeism, unemployment, etc.) and how those costs should be estimated.
Source: PharmacoEconomics - Category: Health Management Source Type: research